chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mind and memory depression; mind and memory depression; tired; sleepy; back pain got worse; shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, intramuscular in right arm on 26Feb2021 10:15, at 65 years of age, (Batch/Lot Number: EL9267) as single dose for COVID-19 immunization. Medical history included knee surgery on 23Jan2019, some tiredness, disability (reported 40% on back and 30% on mental) and mental depression since 1978 and ongoing. The patient had previously received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine on 05Feb2021 at 10:15 AM (Batch/Lot number: E23247), via intramuscular route in left arm and one dose of Flu vaccine on 14Jan2021 in left arm. Concomitant medications included acetaminophen 500 mg twice daily for back pain, lithium carbonate 1 tablet 300 mg for depression and lamotrigine 25 mg 1 tablet daily for depression, all taken since an unknown date and an unspecified medicine for Disability 40% since an unknown date. On 26Feb2021, 8 hours after the second vaccine dose, the patient experienced tired and sleepy "skeleton" and back pain got worse and shoulder pain and, on an unspecified date, he experienced mind and memory depression. No treatment was administered to the patient for the reported events. The events tired and sleepy resolved on 28Feb2021, the event shoulder pain was resolving, whereas the outcome of the events back pain got worse, mind and memory depression was unknown at the time of the report.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 09-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided. Time from first puncture was 14 days.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow was received, contains no new information.
bout of gout; This spontaneous case was reported by a health care professional and describes the occurrence of GOUT (bout of gout) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included NYSTATIN (STATIN [NYSTATIN]) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced GOUT (bout of gout). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, GOUT (bout of gout) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
No other AE; VARIVAX Improperly stored and administered; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided.  On 19-JAN-2021, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose, lot # was reported as T010309 and was confirmed to be valid, expiry date was reported as 24-MAR-2022 and upon internal validation process it was confirmed to be correct (dose number, route of administration and anatomical location were not reported) for prophylaxis. The administered dose of vaccine was exposed to the temperature of -12.8 Celsius degrees (C) for 9 hours and 6 minutes. There was no previous temperature excursions. Digital data logger was involved. The patient did not experienced any other adverse events.
Exactly 12 days after the vaccine I reported a fine rash with small blisters covering the backs of both of my hands with itching and warm redness in them both (I have pictures) Within an hour it began feverish red itching and slight burning on both of The undersides of my forearms. I was advised by the pharmacists on duty in the covid clinic site to use topical Benadryl cream and or take Benadryl by mouth if it worsened. I was told to seek emergency dept help if any signs of breathing issues presented. The next morning the itching was gone the redness subsided and the rash was markedly better but still raised in the tops of my hands.  By 1030am on 1/12/21, I could not detect taste or smell at all. I was advised then to report to employee healthline for further instruction. I was told to leave work and proceed to our employee Covid swab testing drive thru facility for Covid testing and remain home for results the following morning on 1/13/21. At approximately 10am 1/13/21 I was confirmed positive for COVID-19 via the swab results. I was told to quarantine and given a return to work date of 1/24/21 as long as my symptoms were resolved.  I am currently in home quarantine still suffering no taste or smell, muscle cramps in legs, thighs and back. Fatigue, Loss of appetite, sinus pressure and headache not relieved with medications.
Tested positive for COVID-19; Post-nasal drip sensation; Cough; Chills that were almost unnoticeable; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19), UPPER-AIRWAY COUGH SYNDROME (Post-nasal drip sensation), COUGH (Cough) and CHILLS (Chills that were almost unnoticeable) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced UPPER-AIRWAY COUGH SYNDROME (Post-nasal drip sensation), COUGH (Cough) and CHILLS (Chills that were almost unnoticeable). On 21-May-2021, the patient experienced COVID-19 (Tested positive for COVID-19). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive for COVID-19) had not resolved and UPPER-AIRWAY COUGH SYNDROME (Post-nasal drip sensation), COUGH (Cough) and CHILLS (Chills that were almost unnoticeable) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19 via a rapid test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication provided include Top Care Allergy Medication, daily. Treatment provided also include Top Care Allergy Medication.
Narrative: COVID infection following COVID vaccine series 04/08 Janssen, dose #1 07/17 Admit to medicine dx: Acute bronchitis: rhinovirus +, Hypophosphatemia LOS: 1 day 07/17 PCR result: rhinovirus/enterovirus 07/17 MRSA result: not detected 08/05 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, nausea, rhinorrhea, congestion exposure: at work 08/07 COVID swab, result: detected 08/12 SARS-COV-2 LINEAGE B.1 617.2 08/12 SARS-COV-2 CLADE 21A DELTA
High fevers (102.5 - 105) for one week. Body aches, weakness, inability to walk, loss of appetite, persistent cough. Headache. Extreme fatigue.
A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 22 month old male vaccinee inadvertently received Fluvirin on 10/11/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400024.
My bones feel like they are exploding; stabbing pains; brain fog; Involuntary muscle movements; joint/muscle pain; joint/muscle pain; fever chills; hypersensitivity to skin; muscle weakness; migraine; skin burning; rashes; hives; muscles spasms; Dose: 1 Start date: 22Mar2021; Dose: 2 Start date: 08Apr2021; Dose: 1 Start date: 22Mar2021; Dose: 2 Start date: 08Apr2021; This is a spontaneous report from a contactable consumer (patient).   A 34-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP6955, expiration date was not reported), via an unspecified route of administration, administered in the  left arm on 08Apr2021 12:30 at single dose for covid-19 immunisation. Medical history included tachycardia, depression, migraines. Concomitant medications included escitalopram oxalate (LEXAPRO); metoprolol tartrate; clarithromycin (CLARITIN [CLARITHROMYCIN]); topiramate. The patient previously took vicodin and experienced hypersensitivity (known allergies), first dose of bnt162b2 on 22Mar2021 04:00 pm (lot number: EN6207, expiration date was not reported) for covid-19 immunisation. On 08Apr2021 at 14:00, the patient experienced involuntary muscle movements, stabbing pains, joint/muscle pain, brain fog, fever chills, hypersensitivity to skin, muscle weakness, migraine, skin burning, rashes, hives, muscles spasms. This has been the most painful experience of my life and it still isn't over. It gets a little better each day but is still just so painful. I can't believe a vaccine can make someone feel this way. My bones feel like they are exploding. No treatment was given in response to the events. No prior covid vaccination. Not tested for covid post vaccination. Outcome of the events was unknown.
Patient signed up and intended to receive Johnson and Johnsen but mistakenly was administered Pfizer.  No symptoms of note. just wrong intended vaccination.  Patient states most likely will fulfill the series in 3 weeks.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "known allergies: Shellfish" (unspecified if ongoing); "known allergies: Iodine" (unspecified if ongoing); "known allergies: Latex" (unspecified if ongoing). The patient took unspecified concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Tested positive 5 days after testing negative; Positive, notes: Tested positive 5 days after testing negative; Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid (treatment start date: 20Sep2022; treatment stop date: 25Sep2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event  of Anaphylactic reaction. The case will be reassessed once new information is available .
Elevated high blood pressure, chest tightness, cold sweat, hives blood pressure 190/109. Significant t headache and dizziness. Localized swelling and pain to injection site majority symptoms resolved after 2 weeks.
Headaches that progressed to confusion and slurred speech. Diagnosed with TTP requiring PLEX, steroids and Caplacizumab. Course included seizure and ischemic infarct of putamen.  Question of transient STEMI at time of seizure.
Chills, Diarrhea, Headache ,Tiredness  &  no appetite.
pt recv vax 15OCT96 & 31OCT96 pt devel a rash consisting of a lot of red bumps/spots all over;it was noted that the pt did not respond well to vax;
This spontaneous report was received from a Licensed Practical Nurse refers to a 61 year old female patient. No medical history or drug reactions were reported. On 11-SEP-2013, the patient was vaccinated with 0.65 ml dose of ZOSTAVAX (lot # J003808, 03-JUL-2014), subcutaneously. Concomitant therapies included FLONASE, vitamin D (unspecified), ZYRTEC and aspirin. On 18-SEP-2013, the patient was diagnosed with shingles. Patient received treatment with ZOVIRAX. Patient sought medical attention: Office visit. Laboratory Diagnostics Studies Performed included culture swabs, pending results. The outcome of shingles was reported as not recovered. VZVIP packet faxed. Additional information has been requested.
Pt non-converter; neg titers; reporter was not willing to give any info @ the time of this report;
large >1cm erythematous, indurated lesion @ site of inj 120mins p/inj;very pruritic, treated w/DPH
This spontaneous report as received from a pharmacist refers to a male patient of unknown age with rash "on his belly". The patient's medical history was not provided. On 30-DEC-2015, the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose and route were not reported) and then the pharmacist noticed the patient had a rash "on his belly". The pharmacist stated that the patient said that he had developed the rash prior to being vaccinated (drug maladministration). The pharmacist stated also that the patient did not mention this to him prior to vaccination. The pharmacist stated that he did not know if the rash was related to shingles. Follow up information has been received from the pharmacist on 15-FEB-2016, regarding to a 65 year old male patient with possible shingles. The patient's medical history was not reported. On 30-DEC-2015 at 11:00 hours, the patient was vaccinated with the first dose of ZOSTAVAX lot # L016283, subcutaneous, in the right arm. Concomitant therapy was not reported. The pharmacist reported that the patient said that on an unspecified date, after giving vaccination he had rash. Therefore the pharmacist looked at it and it was under a belly fold. Subsequently the patient was advised to go to the emergency room. The outcome of rash was reported as recovered on an unknown date. Additional information is not expected because all the follow ups requested to complete the case were received.
I woke up the morning of the 12/26, with chills and fever the whole night before. That whole day, I felt feverish and headache-y. 12/27 I had fevers, and headaches and brain fog, highest fever 101. I took Tylenol every 6 hours while I was awake. Tuesday, 12/28/2021 fever was 102. Wednesday 12/29 same thing but headaches were the strongest they had ever been. Fatigue. I went to a walk-in clinic and did not have a fever when I was there but that's when I noticed I was light sensitive when I drove myself there. There, she prescribed doxycycline and said this was normal with the vaccine and by then it was 6 days by this point. She suggested for me to go for a walk and ice on back of neck for headaches. That evening I had another 101 fever. I had been setting an alarm to take Tylenol throughout the night. Thursday, headaches still continued so I called my GP and I told them the situation and they had me do a flu & COVID testing and both came back negative. Then they suggested I also do a blood panel for the tick. When I was there, they prescribed me sumatriptan 25mg for migraines. For the first time since my migraines started, I finally had relief for the first time. There was also brain fog. 12/31 brain fog, 01/01 headaches. Christmas day there was also nausea and throughout the symptoms. On Saturday it was the same nausea and weakness and it wasn't as bad because the headaches were finally managed. I had a fever on 12/31 but it was only 99. Saturday 1/1 3 hours where I was not in pain. Sunday 1/2 half the day, I went half the day without any pain. I also did take Tylenol every 6 hours. Today I had a Tylenol this morning for a headache. I've also lost 4 pounds since the beginning of symptoms. Fatigue was also present during duration of symptoms.
a 62 y/o M  who presents with concerns for an allergic reaction to the second dose of the Covid vaccine.  According to him he got the vaccine around 8:45 AM.  He has a history of anaphylactic type reactions with a swelling and urticaria in the past but has not had any symptoms in the last 5 years.  He felt sudden onset pit in his stomach, tingling and warm sensations over his face and some chest tightness.  He denies all the symptoms currently.  He did get medications prior to arrival but states his symptoms were already getting better before he been given anything.  He was given epinephrine as well as Benadryl beforehand.  He denies any symptoms currently.  Denies headache, change in vision, difficulty swallowing, lightheadedness or vertigo, chest pain, sore throat, wheezing, cough, nausea or vomiting, rash, falls or injuries.  Denies any recent foreign travel or sick contacts.  He did work a full shift yesterday and was coming off a 24-hour shift prior to getting his vaccination. He denies any significant reactions to the first vaccine.   Medical Decision Making  On initial presentation is an overall well-appearing 62-year-old male who has normal vital signs without fever or tachycardia.  He is presenting with concern for allergic reaction of the field to a recent vaccination.  The vaccine was given roughly 1 hour prior to arrival. He was given epinephrine intramuscularly as well as IV Benadryl.  He states he is currently feeling mildly tired from the Benadryl. He denies any other recurrent symptomatology and feels better.  Examination is not concerning for anaphylaxis at this time, no evidence of airway involvement or multisystem involvement.  No evidence of local allergic reaction.  Low clinical concern for occult infection, metabolic abnormality, ACS or arrhythmia for a cause of his symptoms.  He is overall very well-appearing.  Labs have been obtained as part of screening for reactions to the vaccination per CDC recommendations including a tryptase and C4 complement.  They were drawn over an hour after the vaccine was administered. ECG was within normal limits.  After observation patient remained asymptomatic.  Did offer steroids, however he wanted to hold off on them as he just got his vaccination which seems appropriate at this time.  He was sent home with a new EpiPen.  We also gave him follow-up in the allergy clinic.  He has any worsening symptoms we do recommend he use the EpiPen as well as call 911.  He is understanding.  At this point he stable for outpatient management.  I did tell him he should expect to feel aches and potentially have inflammatory response to the vaccine, he is understanding of this.  Pt was discharged home/self-care. Pt provided strict return precautions, including but not limited to, any worsening symptoms or any new concerning symptoms. Otherwise, Pt instructed to see PCP on an as needed basis.
After the Moderna booster shot I experienced severe muscle and joint pain. Two days after the shot my left armpit was swollen the size of a golf ball and very painful.
No adverse event. Reporting immunization error: under age, Patient  is 17 years and 4 months old at day of immunization.
Dizzy; rapid pulse; blood pressure went to roof; Extremely white; Weak; A spontaneous report was received from a consumer (patient) concerning 72 years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).  The patient's medical history was not reported. The concomitant medications included warfarin sodium for twenty years and blood thinner pills.  On 04 Feb 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot: 039K20A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 04 Feb 2021, the patient reported that after the shot she felt very dizzy, weak, had very rapid pulse, blood pressure went to roof, did not have any other severe allergic reaction, her oxygen level was okay. The nurse told her she was extremely white and they put the mask away. On the same day, after 15 minutes her oxygen was still good, blood pressure started getting better, no swelling. On the same day, after 15 minutes more she was getting better, had no problems in her throat and no trouble breathing. After the 30 minutes nurse asked her to stay 15 minutes more, she waited and everything was fine, she had no other reaction or other side effects.  Treatment received for the event was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  On 04 Feb 2021, the events of dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia) were resolved.  The reporter did not provide assessment for the events dizzy, rapid pulse (heart rate increased), blood pressure went to roof (hypertension), extremely white (pallor), weak (asthenia).; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Information has been received from a registered nurse for VARIVAX (Merck), a Pregnancy Registry product, concerning a 36 year old female patient with Gilbert's syndrome who on 22-SEP-2009 and 20-OCT-2009 was vaccinated with the first and second dose of VARIVAX (Merck) (lot# for both vaccinations was 665191/1047Y) while she may have been pregnant. The registered nurse stated that the vaccine was given at another physician's office and was not given in their office. Concomitant therapy included prenatal vitamins. The registered nurse also reported that the patient had redness and swelling at the injection site after the first dose of VARIVAX (Merck) was given. There was no adverse reaction reported after the second dose of VARIVAX (Merck). Medical attention was sought, the patient had an office visit. It was unspecified if lab studies were performed. At the time of the report, the patient's status was unknown. It was noted that the patient would be followed by another physician's office for prenatal care. Additional information has been requested.
Acute myocarditis.  Lymph node swelling in neck and throat area.  Coughing spells.  Pleuritic Chest Pain, Headache, Fever.               Admitted 5/20/22.  Given colchicine and indomethacin .  PTCA of the RCA